A historic shift in Canadian drug policy has happened, as the regulators permit the use of psilocybin mushrooms for therapeutic treatment. Until now, these substances were severely restricted, but a growing body of research suggests they potentially offer benefits for emotional issues like anxiety. This change represents a substantial step toward r